Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2021-05-04 Major Shareholding Noti…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with 'RNS Number : 4981X' and contains the standard boilerplate text indicating it is provided by 'RNS, the news service of the London Stock Exchange'. The content itself is a 'TR-1: Standard form for notification of major holdings' filed by BlackRock, Inc. regarding Dechra Pharmaceuticals PLC. This type of filing, which reports changes in significant share ownership (crossing thresholds), is a mandatory regulatory disclosure. Since there is no specific category for 'Major Holding Notification' and it is a regulatory announcement distributed via RNS, the most appropriate classification is 'Major Shareholding Notification' (MRQ) if available, or the general regulatory fallback 'RNS'. Reviewing the definitions, MRQ is 'Major Shareholding Notification' and RNS is 'General regulatory announcements and fallback category'. Given the highly specific nature of the content (TR-1 Major Holding Notification), MRQ is the best fit, as it directly describes the content type, even if RNS is the distribution channel.
2021-05-04 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and is issued via 'RNS Number : 4223X' by Dechra Pharmaceuticals PLC on May 4, 2021. It details changes in voting rights held by BlackRock, Inc., crossing a notification threshold (from 4.99% to 5.04%). This type of mandatory disclosure regarding significant changes in share ownership is specifically covered by the 'Major Shareholding Notification' category. It is not an Annual Report (10-K), Earnings Release (ER), or a general regulatory filing (RNS), as it pertains to a very specific regulatory event (insider/major shareholder transaction reporting). Therefore, the most appropriate code is MRQ.
2021-05-04 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with "RNS Number : 2923X" and contains the header "National Storage Mechanism | Additional information". The content details a TR-1 form, which is a standard form for notifying major holdings (shareholder changes crossing a threshold). This type of mandatory regulatory disclosure, especially when originating from RNS (the news service of the London Stock Exchange), falls under the category of significant shareholder notifications. The specific filing type that covers changes in significant share ownership levels (crossing thresholds) is 'Major Shareholding Notification' (MRQ). Although it is an RNS filing, MRQ is more specific and accurate than the general RNS fallback.
2021-04-30 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details the 'Total Voting Rights' as of the announcement date (30 April 2021), which is a mandatory regulatory disclosure under DTR 5.6.1R. This type of general, mandatory regulatory announcement that doesn't fit a more specific category like Director's Dealing (DIRS) or Major Shareholding Notification (MRQ) is best classified as a general Regulatory Filing (RNS). The document length is short (2913 chars), supporting the classification as a brief regulatory notice rather than a comprehensive report.
2021-04-30 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 9515W' and contains the standard boilerplate text indicating it is provided by RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. The content itself is a 'TR-1: Standard form for notification of major holdings' concerning BlackRock, Inc. crossing a voting rights threshold (5.520000%). This type of mandatory disclosure regarding changes in significant share ownership is specifically covered by the 'Major Shareholding Notification' definition. Therefore, the appropriate code is MRQ.
2021-04-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement, indicated by the 'RNS Number' header and the concluding paragraph mentioning RNS and the London Stock Exchange. The content details a 'TR-1: Standard form for notification of major holdings' concerning BlackRock, Inc. crossing a threshold of voting rights in Dechra Pharmaceuticals PLC. This type of mandatory disclosure regarding significant changes in share ownership falls under regulatory reporting. Since there is a specific category for 'Major Shareholding Notification' (MRQ), that is the most precise classification. Although it is distributed via RNS, the core content is a specific regulatory filing type.
2021-04-27 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.